Global Minimal Residual Disease Testing Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Minimal Residual Disease Testing market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Minimal Residual Disease Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Minimal Residual Disease Testing market size and forecasts, in consumption value ($ Million), 2020-2031
Global Minimal Residual Disease Testing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Minimal Residual Disease Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Minimal Residual Disease Testing market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Minimal Residual Disease Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Minimal Residual Disease Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Adaptive Biotechnologies, ArcherDX, ARUP Laboratories, Asuragen, F. Hoffmann-La Roche, Guardant Health, Labcorp, NeoGenomics Laboratories, Sysmex Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Minimal Residual Disease Testing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Minimal Residual Disease Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Minimal Residual Disease Testing, with revenue, gross margin, and global market share of Minimal Residual Disease Testing from 2020 to 2025.
Chapter 3, the Minimal Residual Disease Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Minimal Residual Disease Testing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Minimal Residual Disease Testing.
Chapter 13, to describe Minimal Residual Disease Testing research findings and conclusion.
This report is a detailed and comprehensive analysis for global Minimal Residual Disease Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Minimal Residual Disease Testing market size and forecasts, in consumption value ($ Million), 2020-2031
Global Minimal Residual Disease Testing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Minimal Residual Disease Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Minimal Residual Disease Testing market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Minimal Residual Disease Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Minimal Residual Disease Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Adaptive Biotechnologies, ArcherDX, ARUP Laboratories, Asuragen, F. Hoffmann-La Roche, Guardant Health, Labcorp, NeoGenomics Laboratories, Sysmex Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Minimal Residual Disease Testing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Flow Cytometry
- Polymerase Chain Reaction
- Hospitals and Specialty Clinics
- Diagnostic Laboratories
- Academic and Research Institutes
- Others
- Adaptive Biotechnologies
- ArcherDX
- ARUP Laboratories
- Asuragen
- F. Hoffmann-La Roche
- Guardant Health
- Labcorp
- NeoGenomics Laboratories
- Sysmex Corporation
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Minimal Residual Disease Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Minimal Residual Disease Testing, with revenue, gross margin, and global market share of Minimal Residual Disease Testing from 2020 to 2025.
Chapter 3, the Minimal Residual Disease Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Minimal Residual Disease Testing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Minimal Residual Disease Testing.
Chapter 13, to describe Minimal Residual Disease Testing research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Minimal Residual Disease Testing by Type
1.3.1 Overview: Global Minimal Residual Disease Testing Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Minimal Residual Disease Testing Consumption Value Market Share by Type in 2024
1.3.3 Flow Cytometry
1.3.4 Polymerase Chain Reaction
1.4 Global Minimal Residual Disease Testing Market by Application
1.4.1 Overview: Global Minimal Residual Disease Testing Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals and Specialty Clinics
1.4.3 Diagnostic Laboratories
1.4.4 Academic and Research Institutes
1.4.5 Others
1.5 Global Minimal Residual Disease Testing Market Size & Forecast
1.6 Global Minimal Residual Disease Testing Market Size and Forecast by Region
1.6.1 Global Minimal Residual Disease Testing Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Minimal Residual Disease Testing Market Size by Region, (2020-2031)
1.6.3 North America Minimal Residual Disease Testing Market Size and Prospect (2020-2031)
1.6.4 Europe Minimal Residual Disease Testing Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Minimal Residual Disease Testing Market Size and Prospect (2020-2031)
1.6.6 South America Minimal Residual Disease Testing Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Minimal Residual Disease Testing Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Adaptive Biotechnologies
2.1.1 Adaptive Biotechnologies Details
2.1.2 Adaptive Biotechnologies Major Business
2.1.3 Adaptive Biotechnologies Minimal Residual Disease Testing Product and Solutions
2.1.4 Adaptive Biotechnologies Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Adaptive Biotechnologies Recent Developments and Future Plans
2.2 ArcherDX
2.2.1 ArcherDX Details
2.2.2 ArcherDX Major Business
2.2.3 ArcherDX Minimal Residual Disease Testing Product and Solutions
2.2.4 ArcherDX Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 ArcherDX Recent Developments and Future Plans
2.3 ARUP Laboratories
2.3.1 ARUP Laboratories Details
2.3.2 ARUP Laboratories Major Business
2.3.3 ARUP Laboratories Minimal Residual Disease Testing Product and Solutions
2.3.4 ARUP Laboratories Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 ARUP Laboratories Recent Developments and Future Plans
2.4 Asuragen
2.4.1 Asuragen Details
2.4.2 Asuragen Major Business
2.4.3 Asuragen Minimal Residual Disease Testing Product and Solutions
2.4.4 Asuragen Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Asuragen Recent Developments and Future Plans
2.5 F. Hoffmann-La Roche
2.5.1 F. Hoffmann-La Roche Details
2.5.2 F. Hoffmann-La Roche Major Business
2.5.3 F. Hoffmann-La Roche Minimal Residual Disease Testing Product and Solutions
2.5.4 F. Hoffmann-La Roche Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.6 Guardant Health
2.6.1 Guardant Health Details
2.6.2 Guardant Health Major Business
2.6.3 Guardant Health Minimal Residual Disease Testing Product and Solutions
2.6.4 Guardant Health Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Guardant Health Recent Developments and Future Plans
2.7 Labcorp
2.7.1 Labcorp Details
2.7.2 Labcorp Major Business
2.7.3 Labcorp Minimal Residual Disease Testing Product and Solutions
2.7.4 Labcorp Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Labcorp Recent Developments and Future Plans
2.8 NeoGenomics Laboratories
2.8.1 NeoGenomics Laboratories Details
2.8.2 NeoGenomics Laboratories Major Business
2.8.3 NeoGenomics Laboratories Minimal Residual Disease Testing Product and Solutions
2.8.4 NeoGenomics Laboratories Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 NeoGenomics Laboratories Recent Developments and Future Plans
2.9 Sysmex Corporation
2.9.1 Sysmex Corporation Details
2.9.2 Sysmex Corporation Major Business
2.9.3 Sysmex Corporation Minimal Residual Disease Testing Product and Solutions
2.9.4 Sysmex Corporation Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Sysmex Corporation Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Minimal Residual Disease Testing Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Minimal Residual Disease Testing by Company Revenue
3.2.2 Top 3 Minimal Residual Disease Testing Players Market Share in 2024
3.2.3 Top 6 Minimal Residual Disease Testing Players Market Share in 2024
3.3 Minimal Residual Disease Testing Market: Overall Company Footprint Analysis
3.3.1 Minimal Residual Disease Testing Market: Region Footprint
3.3.2 Minimal Residual Disease Testing Market: Company Product Type Footprint
3.3.3 Minimal Residual Disease Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Minimal Residual Disease Testing Consumption Value and Market Share by Type (2020-2025)
4.2 Global Minimal Residual Disease Testing Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Minimal Residual Disease Testing Consumption Value Market Share by Application (2020-2025)
5.2 Global Minimal Residual Disease Testing Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Minimal Residual Disease Testing Consumption Value by Type (2020-2031)
6.2 North America Minimal Residual Disease Testing Market Size by Application (2020-2031)
6.3 North America Minimal Residual Disease Testing Market Size by Country
6.3.1 North America Minimal Residual Disease Testing Consumption Value by Country (2020-2031)
6.3.2 United States Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
6.3.3 Canada Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
6.3.4 Mexico Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Minimal Residual Disease Testing Consumption Value by Type (2020-2031)
7.2 Europe Minimal Residual Disease Testing Consumption Value by Application (2020-2031)
7.3 Europe Minimal Residual Disease Testing Market Size by Country
7.3.1 Europe Minimal Residual Disease Testing Consumption Value by Country (2020-2031)
7.3.2 Germany Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
7.3.3 France Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
7.3.5 Russia Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
7.3.6 Italy Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Minimal Residual Disease Testing Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Minimal Residual Disease Testing Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Minimal Residual Disease Testing Market Size by Region
8.3.1 Asia-Pacific Minimal Residual Disease Testing Consumption Value by Region (2020-2031)
8.3.2 China Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
8.3.3 Japan Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
8.3.4 South Korea Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
8.3.5 India Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
8.3.7 Australia Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Minimal Residual Disease Testing Consumption Value by Type (2020-2031)
9.2 South America Minimal Residual Disease Testing Consumption Value by Application (2020-2031)
9.3 South America Minimal Residual Disease Testing Market Size by Country
9.3.1 South America Minimal Residual Disease Testing Consumption Value by Country (2020-2031)
9.3.2 Brazil Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
9.3.3 Argentina Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Minimal Residual Disease Testing Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Minimal Residual Disease Testing Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Minimal Residual Disease Testing Market Size by Country
10.3.1 Middle East & Africa Minimal Residual Disease Testing Consumption Value by Country (2020-2031)
10.3.2 Turkey Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
10.3.4 UAE Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Minimal Residual Disease Testing Market Drivers
11.2 Minimal Residual Disease Testing Market Restraints
11.3 Minimal Residual Disease Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Minimal Residual Disease Testing Industry Chain
12.2 Minimal Residual Disease Testing Upstream Analysis
12.3 Minimal Residual Disease Testing Midstream Analysis
12.4 Minimal Residual Disease Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Minimal Residual Disease Testing by Type
1.3.1 Overview: Global Minimal Residual Disease Testing Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Minimal Residual Disease Testing Consumption Value Market Share by Type in 2024
1.3.3 Flow Cytometry
1.3.4 Polymerase Chain Reaction
1.4 Global Minimal Residual Disease Testing Market by Application
1.4.1 Overview: Global Minimal Residual Disease Testing Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals and Specialty Clinics
1.4.3 Diagnostic Laboratories
1.4.4 Academic and Research Institutes
1.4.5 Others
1.5 Global Minimal Residual Disease Testing Market Size & Forecast
1.6 Global Minimal Residual Disease Testing Market Size and Forecast by Region
1.6.1 Global Minimal Residual Disease Testing Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Minimal Residual Disease Testing Market Size by Region, (2020-2031)
1.6.3 North America Minimal Residual Disease Testing Market Size and Prospect (2020-2031)
1.6.4 Europe Minimal Residual Disease Testing Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Minimal Residual Disease Testing Market Size and Prospect (2020-2031)
1.6.6 South America Minimal Residual Disease Testing Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Minimal Residual Disease Testing Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Adaptive Biotechnologies
2.1.1 Adaptive Biotechnologies Details
2.1.2 Adaptive Biotechnologies Major Business
2.1.3 Adaptive Biotechnologies Minimal Residual Disease Testing Product and Solutions
2.1.4 Adaptive Biotechnologies Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Adaptive Biotechnologies Recent Developments and Future Plans
2.2 ArcherDX
2.2.1 ArcherDX Details
2.2.2 ArcherDX Major Business
2.2.3 ArcherDX Minimal Residual Disease Testing Product and Solutions
2.2.4 ArcherDX Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 ArcherDX Recent Developments and Future Plans
2.3 ARUP Laboratories
2.3.1 ARUP Laboratories Details
2.3.2 ARUP Laboratories Major Business
2.3.3 ARUP Laboratories Minimal Residual Disease Testing Product and Solutions
2.3.4 ARUP Laboratories Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 ARUP Laboratories Recent Developments and Future Plans
2.4 Asuragen
2.4.1 Asuragen Details
2.4.2 Asuragen Major Business
2.4.3 Asuragen Minimal Residual Disease Testing Product and Solutions
2.4.4 Asuragen Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Asuragen Recent Developments and Future Plans
2.5 F. Hoffmann-La Roche
2.5.1 F. Hoffmann-La Roche Details
2.5.2 F. Hoffmann-La Roche Major Business
2.5.3 F. Hoffmann-La Roche Minimal Residual Disease Testing Product and Solutions
2.5.4 F. Hoffmann-La Roche Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.6 Guardant Health
2.6.1 Guardant Health Details
2.6.2 Guardant Health Major Business
2.6.3 Guardant Health Minimal Residual Disease Testing Product and Solutions
2.6.4 Guardant Health Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Guardant Health Recent Developments and Future Plans
2.7 Labcorp
2.7.1 Labcorp Details
2.7.2 Labcorp Major Business
2.7.3 Labcorp Minimal Residual Disease Testing Product and Solutions
2.7.4 Labcorp Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Labcorp Recent Developments and Future Plans
2.8 NeoGenomics Laboratories
2.8.1 NeoGenomics Laboratories Details
2.8.2 NeoGenomics Laboratories Major Business
2.8.3 NeoGenomics Laboratories Minimal Residual Disease Testing Product and Solutions
2.8.4 NeoGenomics Laboratories Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 NeoGenomics Laboratories Recent Developments and Future Plans
2.9 Sysmex Corporation
2.9.1 Sysmex Corporation Details
2.9.2 Sysmex Corporation Major Business
2.9.3 Sysmex Corporation Minimal Residual Disease Testing Product and Solutions
2.9.4 Sysmex Corporation Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Sysmex Corporation Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Minimal Residual Disease Testing Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Minimal Residual Disease Testing by Company Revenue
3.2.2 Top 3 Minimal Residual Disease Testing Players Market Share in 2024
3.2.3 Top 6 Minimal Residual Disease Testing Players Market Share in 2024
3.3 Minimal Residual Disease Testing Market: Overall Company Footprint Analysis
3.3.1 Minimal Residual Disease Testing Market: Region Footprint
3.3.2 Minimal Residual Disease Testing Market: Company Product Type Footprint
3.3.3 Minimal Residual Disease Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Minimal Residual Disease Testing Consumption Value and Market Share by Type (2020-2025)
4.2 Global Minimal Residual Disease Testing Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Minimal Residual Disease Testing Consumption Value Market Share by Application (2020-2025)
5.2 Global Minimal Residual Disease Testing Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Minimal Residual Disease Testing Consumption Value by Type (2020-2031)
6.2 North America Minimal Residual Disease Testing Market Size by Application (2020-2031)
6.3 North America Minimal Residual Disease Testing Market Size by Country
6.3.1 North America Minimal Residual Disease Testing Consumption Value by Country (2020-2031)
6.3.2 United States Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
6.3.3 Canada Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
6.3.4 Mexico Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Minimal Residual Disease Testing Consumption Value by Type (2020-2031)
7.2 Europe Minimal Residual Disease Testing Consumption Value by Application (2020-2031)
7.3 Europe Minimal Residual Disease Testing Market Size by Country
7.3.1 Europe Minimal Residual Disease Testing Consumption Value by Country (2020-2031)
7.3.2 Germany Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
7.3.3 France Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
7.3.5 Russia Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
7.3.6 Italy Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Minimal Residual Disease Testing Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Minimal Residual Disease Testing Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Minimal Residual Disease Testing Market Size by Region
8.3.1 Asia-Pacific Minimal Residual Disease Testing Consumption Value by Region (2020-2031)
8.3.2 China Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
8.3.3 Japan Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
8.3.4 South Korea Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
8.3.5 India Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
8.3.7 Australia Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Minimal Residual Disease Testing Consumption Value by Type (2020-2031)
9.2 South America Minimal Residual Disease Testing Consumption Value by Application (2020-2031)
9.3 South America Minimal Residual Disease Testing Market Size by Country
9.3.1 South America Minimal Residual Disease Testing Consumption Value by Country (2020-2031)
9.3.2 Brazil Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
9.3.3 Argentina Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Minimal Residual Disease Testing Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Minimal Residual Disease Testing Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Minimal Residual Disease Testing Market Size by Country
10.3.1 Middle East & Africa Minimal Residual Disease Testing Consumption Value by Country (2020-2031)
10.3.2 Turkey Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
10.3.4 UAE Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Minimal Residual Disease Testing Market Drivers
11.2 Minimal Residual Disease Testing Market Restraints
11.3 Minimal Residual Disease Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Minimal Residual Disease Testing Industry Chain
12.2 Minimal Residual Disease Testing Upstream Analysis
12.3 Minimal Residual Disease Testing Midstream Analysis
12.4 Minimal Residual Disease Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF FIGURES
Table 1. Global Minimal Residual Disease Testing Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Minimal Residual Disease Testing Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Minimal Residual Disease Testing Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Minimal Residual Disease Testing Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Adaptive Biotechnologies Company Information, Head Office, and Major Competitors
Table 6. Adaptive Biotechnologies Major Business
Table 7. Adaptive Biotechnologies Minimal Residual Disease Testing Product and Solutions
Table 8. Adaptive Biotechnologies Minimal Residual Disease Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Adaptive Biotechnologies Recent Developments and Future Plans
Table 10. ArcherDX Company Information, Head Office, and Major Competitors
Table 11. ArcherDX Major Business
Table 12. ArcherDX Minimal Residual Disease Testing Product and Solutions
Table 13. ArcherDX Minimal Residual Disease Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. ArcherDX Recent Developments and Future Plans
Table 15. ARUP Laboratories Company Information, Head Office, and Major Competitors
Table 16. ARUP Laboratories Major Business
Table 17. ARUP Laboratories Minimal Residual Disease Testing Product and Solutions
Table 18. ARUP Laboratories Minimal Residual Disease Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Asuragen Company Information, Head Office, and Major Competitors
Table 20. Asuragen Major Business
Table 21. Asuragen Minimal Residual Disease Testing Product and Solutions
Table 22. Asuragen Minimal Residual Disease Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Asuragen Recent Developments and Future Plans
Table 24. F. Hoffmann-La Roche Company Information, Head Office, and Major Competitors
Table 25. F. Hoffmann-La Roche Major Business
Table 26. F. Hoffmann-La Roche Minimal Residual Disease Testing Product and Solutions
Table 27. F. Hoffmann-La Roche Minimal Residual Disease Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. F. Hoffmann-La Roche Recent Developments and Future Plans
Table 29. Guardant Health Company Information, Head Office, and Major Competitors
Table 30. Guardant Health Major Business
Table 31. Guardant Health Minimal Residual Disease Testing Product and Solutions
Table 32. Guardant Health Minimal Residual Disease Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Guardant Health Recent Developments and Future Plans
Table 34. Labcorp Company Information, Head Office, and Major Competitors
Table 35. Labcorp Major Business
Table 36. Labcorp Minimal Residual Disease Testing Product and Solutions
Table 37. Labcorp Minimal Residual Disease Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Labcorp Recent Developments and Future Plans
Table 39. NeoGenomics Laboratories Company Information, Head Office, and Major Competitors
Table 40. NeoGenomics Laboratories Major Business
Table 41. NeoGenomics Laboratories Minimal Residual Disease Testing Product and Solutions
Table 42. NeoGenomics Laboratories Minimal Residual Disease Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. NeoGenomics Laboratories Recent Developments and Future Plans
Table 44. Sysmex Corporation Company Information, Head Office, and Major Competitors
Table 45. Sysmex Corporation Major Business
Table 46. Sysmex Corporation Minimal Residual Disease Testing Product and Solutions
Table 47. Sysmex Corporation Minimal Residual Disease Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Sysmex Corporation Recent Developments and Future Plans
Table 49. Global Minimal Residual Disease Testing Revenue (USD Million) by Players (2020-2025)
Table 50. Global Minimal Residual Disease Testing Revenue Share by Players (2020-2025)
Table 51. Breakdown of Minimal Residual Disease Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 52. Market Position of Players in Minimal Residual Disease Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 53. Head Office of Key Minimal Residual Disease Testing Players
Table 54. Minimal Residual Disease Testing Market: Company Product Type Footprint
Table 55. Minimal Residual Disease Testing Market: Company Product Application Footprint
Table 56. Minimal Residual Disease Testing New Market Entrants and Barriers to Market Entry
Table 57. Minimal Residual Disease Testing Mergers, Acquisition, Agreements, and Collaborations
Table 58. Global Minimal Residual Disease Testing Consumption Value (USD Million) by Type (2020-2025)
Table 59. Global Minimal Residual Disease Testing Consumption Value Share by Type (2020-2025)
Table 60. Global Minimal Residual Disease Testing Consumption Value Forecast by Type (2026-2031)
Table 61. Global Minimal Residual Disease Testing Consumption Value by Application (2020-2025)
Table 62. Global Minimal Residual Disease Testing Consumption Value Forecast by Application (2026-2031)
Table 63. North America Minimal Residual Disease Testing Consumption Value by Type (2020-2025) & (USD Million)
Table 64. North America Minimal Residual Disease Testing Consumption Value by Type (2026-2031) & (USD Million)
Table 65. North America Minimal Residual Disease Testing Consumption Value by Application (2020-2025) & (USD Million)
Table 66. North America Minimal Residual Disease Testing Consumption Value by Application (2026-2031) & (USD Million)
Table 67. North America Minimal Residual Disease Testing Consumption Value by Country (2020-2025) & (USD Million)
Table 68. North America Minimal Residual Disease Testing Consumption Value by Country (2026-2031) & (USD Million)
Table 69. Europe Minimal Residual Disease Testing Consumption Value by Type (2020-2025) & (USD Million)
Table 70. Europe Minimal Residual Disease Testing Consumption Value by Type (2026-2031) & (USD Million)
Table 71. Europe Minimal Residual Disease Testing Consumption Value by Application (2020-2025) & (USD Million)
Table 72. Europe Minimal Residual Disease Testing Consumption Value by Application (2026-2031) & (USD Million)
Table 73. Europe Minimal Residual Disease Testing Consumption Value by Country (2020-2025) & (USD Million)
Table 74. Europe Minimal Residual Disease Testing Consumption Value by Country (2026-2031) & (USD Million)
Table 75. Asia-Pacific Minimal Residual Disease Testing Consumption Value by Type (2020-2025) & (USD Million)
Table 76. Asia-Pacific Minimal Residual Disease Testing Consumption Value by Type (2026-2031) & (USD Million)
Table 77. Asia-Pacific Minimal Residual Disease Testing Consumption Value by Application (2020-2025) & (USD Million)
Table 78. Asia-Pacific Minimal Residual Disease Testing Consumption Value by Application (2026-2031) & (USD Million)
Table 79. Asia-Pacific Minimal Residual Disease Testing Consumption Value by Region (2020-2025) & (USD Million)
Table 80. Asia-Pacific Minimal Residual Disease Testing Consumption Value by Region (2026-2031) & (USD Million)
Table 81. South America Minimal Residual Disease Testing Consumption Value by Type (2020-2025) & (USD Million)
Table 82. South America Minimal Residual Disease Testing Consumption Value by Type (2026-2031) & (USD Million)
Table 83. South America Minimal Residual Disease Testing Consumption Value by Application (2020-2025) & (USD Million)
Table 84. South America Minimal Residual Disease Testing Consumption Value by Application (2026-2031) & (USD Million)
Table 85. South America Minimal Residual Disease Testing Consumption Value by Country (2020-2025) & (USD Million)
Table 86. South America Minimal Residual Disease Testing Consumption Value by Country (2026-2031) & (USD Million)
Table 87. Middle East & Africa Minimal Residual Disease Testing Consumption Value by Type (2020-2025) & (USD Million)
Table 88. Middle East & Africa Minimal Residual Disease Testing Consumption Value by Type (2026-2031) & (USD Million)
Table 89. Middle East & Africa Minimal Residual Disease Testing Consumption Value by Application (2020-2025) & (USD Million)
Table 90. Middle East & Africa Minimal Residual Disease Testing Consumption Value by Application (2026-2031) & (USD Million)
Table 91. Middle East & Africa Minimal Residual Disease Testing Consumption Value by Country (2020-2025) & (USD Million)
Table 92. Middle East & Africa Minimal Residual Disease Testing Consumption Value by Country (2026-2031) & (USD Million)
Table 93. Global Key Players of Minimal Residual Disease Testing Upstream (Raw Materials)
Table 94. Global Minimal Residual Disease Testing Typical Customers
LIST OF FIGURES
Figure 1. Minimal Residual Disease Testing Picture
Figure 2. Global Minimal Residual Disease Testing Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Minimal Residual Disease Testing Consumption Value Market Share by Type in 2024
Figure 4. Flow Cytometry
Figure 5. Polymerase Chain Reaction
Figure 6. Global Minimal Residual Disease Testing Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Minimal Residual Disease Testing Consumption Value Market Share by Application in 2024
Figure 8. Hospitals and Specialty Clinics Picture
Figure 9. Diagnostic Laboratories Picture
Figure 10. Academic and Research Institutes Picture
Figure 11. Others Picture
Figure 12. Global Minimal Residual Disease Testing Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Minimal Residual Disease Testing Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Market Minimal Residual Disease Testing Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 15. Global Minimal Residual Disease Testing Consumption Value Market Share by Region (2020-2031)
Figure 16. Global Minimal Residual Disease Testing Consumption Value Market Share by Region in 2024
Figure 17. North America Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 18. Europe Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 19. Asia-Pacific Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 20. South America Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 21. Middle East & Africa Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 22. Company Three Recent Developments and Future Plans
Figure 23. Global Minimal Residual Disease Testing Revenue Share by Players in 2024
Figure 24. Minimal Residual Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 25. Market Share of Minimal Residual Disease Testing by Player Revenue in 2024
Figure 26. Top 3 Minimal Residual Disease Testing Players Market Share in 2024
Figure 27. Top 6 Minimal Residual Disease Testing Players Market Share in 2024
Figure 28. Global Minimal Residual Disease Testing Consumption Value Share by Type (2020-2025)
Figure 29. Global Minimal Residual Disease Testing Market Share Forecast by Type (2026-2031)
Figure 30. Global Minimal Residual Disease Testing Consumption Value Share by Application (2020-2025)
Figure 31. Global Minimal Residual Disease Testing Market Share Forecast by Application (2026-2031)
Figure 32. North America Minimal Residual Disease Testing Consumption Value Market Share by Type (2020-2031)
Figure 33. North America Minimal Residual Disease Testing Consumption Value Market Share by Application (2020-2031)
Figure 34. North America Minimal Residual Disease Testing Consumption Value Market Share by Country (2020-2031)
Figure 35. United States Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 36. Canada Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 37. Mexico Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 38. Europe Minimal Residual Disease Testing Consumption Value Market Share by Type (2020-2031)
Figure 39. Europe Minimal Residual Disease Testing Consumption Value Market Share by Application (2020-2031)
Figure 40. Europe Minimal Residual Disease Testing Consumption Value Market Share by Country (2020-2031)
Figure 41. Germany Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 42. France Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 43. United Kingdom Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 44. Russia Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 45. Italy Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 46. Asia-Pacific Minimal Residual Disease Testing Consumption Value Market Share by Type (2020-2031)
Figure 47. Asia-Pacific Minimal Residual Disease Testing Consumption Value Market Share by Application (2020-2031)
Figure 48. Asia-Pacific Minimal Residual Disease Testing Consumption Value Market Share by Region (2020-2031)
Figure 49. China Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 50. Japan Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 51. South Korea Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 52. India Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 53. Southeast Asia Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 54. Australia Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 55. South America Minimal Residual Disease Testing Consumption Value Market Share by Type (2020-2031)
Figure 56. South America Minimal Residual Disease Testing Consumption Value Market Share by Application (2020-2031)
Figure 57. South America Minimal Residual Disease Testing Consumption Value Market Share by Country (2020-2031)
Figure 58. Brazil Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 59. Argentina Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 60. Middle East & Africa Minimal Residual Disease Testing Consumption Value Market Share by Type (2020-2031)
Figure 61. Middle East & Africa Minimal Residual Disease Testing Consumption Value Market Share by Application (2020-2031)
Figure 62. Middle East & Africa Minimal Residual Disease Testing Consumption Value Market Share by Country (2020-2031)
Figure 63. Turkey Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 64. Saudi Arabia Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 65. UAE Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 66. Minimal Residual Disease Testing Market Drivers
Figure 67. Minimal Residual Disease Testing Market Restraints
Figure 68. Minimal Residual Disease Testing Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Minimal Residual Disease Testing Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Table 1. Global Minimal Residual Disease Testing Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Minimal Residual Disease Testing Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Minimal Residual Disease Testing Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Minimal Residual Disease Testing Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Adaptive Biotechnologies Company Information, Head Office, and Major Competitors
Table 6. Adaptive Biotechnologies Major Business
Table 7. Adaptive Biotechnologies Minimal Residual Disease Testing Product and Solutions
Table 8. Adaptive Biotechnologies Minimal Residual Disease Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Adaptive Biotechnologies Recent Developments and Future Plans
Table 10. ArcherDX Company Information, Head Office, and Major Competitors
Table 11. ArcherDX Major Business
Table 12. ArcherDX Minimal Residual Disease Testing Product and Solutions
Table 13. ArcherDX Minimal Residual Disease Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. ArcherDX Recent Developments and Future Plans
Table 15. ARUP Laboratories Company Information, Head Office, and Major Competitors
Table 16. ARUP Laboratories Major Business
Table 17. ARUP Laboratories Minimal Residual Disease Testing Product and Solutions
Table 18. ARUP Laboratories Minimal Residual Disease Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Asuragen Company Information, Head Office, and Major Competitors
Table 20. Asuragen Major Business
Table 21. Asuragen Minimal Residual Disease Testing Product and Solutions
Table 22. Asuragen Minimal Residual Disease Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Asuragen Recent Developments and Future Plans
Table 24. F. Hoffmann-La Roche Company Information, Head Office, and Major Competitors
Table 25. F. Hoffmann-La Roche Major Business
Table 26. F. Hoffmann-La Roche Minimal Residual Disease Testing Product and Solutions
Table 27. F. Hoffmann-La Roche Minimal Residual Disease Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. F. Hoffmann-La Roche Recent Developments and Future Plans
Table 29. Guardant Health Company Information, Head Office, and Major Competitors
Table 30. Guardant Health Major Business
Table 31. Guardant Health Minimal Residual Disease Testing Product and Solutions
Table 32. Guardant Health Minimal Residual Disease Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Guardant Health Recent Developments and Future Plans
Table 34. Labcorp Company Information, Head Office, and Major Competitors
Table 35. Labcorp Major Business
Table 36. Labcorp Minimal Residual Disease Testing Product and Solutions
Table 37. Labcorp Minimal Residual Disease Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Labcorp Recent Developments and Future Plans
Table 39. NeoGenomics Laboratories Company Information, Head Office, and Major Competitors
Table 40. NeoGenomics Laboratories Major Business
Table 41. NeoGenomics Laboratories Minimal Residual Disease Testing Product and Solutions
Table 42. NeoGenomics Laboratories Minimal Residual Disease Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. NeoGenomics Laboratories Recent Developments and Future Plans
Table 44. Sysmex Corporation Company Information, Head Office, and Major Competitors
Table 45. Sysmex Corporation Major Business
Table 46. Sysmex Corporation Minimal Residual Disease Testing Product and Solutions
Table 47. Sysmex Corporation Minimal Residual Disease Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Sysmex Corporation Recent Developments and Future Plans
Table 49. Global Minimal Residual Disease Testing Revenue (USD Million) by Players (2020-2025)
Table 50. Global Minimal Residual Disease Testing Revenue Share by Players (2020-2025)
Table 51. Breakdown of Minimal Residual Disease Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 52. Market Position of Players in Minimal Residual Disease Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 53. Head Office of Key Minimal Residual Disease Testing Players
Table 54. Minimal Residual Disease Testing Market: Company Product Type Footprint
Table 55. Minimal Residual Disease Testing Market: Company Product Application Footprint
Table 56. Minimal Residual Disease Testing New Market Entrants and Barriers to Market Entry
Table 57. Minimal Residual Disease Testing Mergers, Acquisition, Agreements, and Collaborations
Table 58. Global Minimal Residual Disease Testing Consumption Value (USD Million) by Type (2020-2025)
Table 59. Global Minimal Residual Disease Testing Consumption Value Share by Type (2020-2025)
Table 60. Global Minimal Residual Disease Testing Consumption Value Forecast by Type (2026-2031)
Table 61. Global Minimal Residual Disease Testing Consumption Value by Application (2020-2025)
Table 62. Global Minimal Residual Disease Testing Consumption Value Forecast by Application (2026-2031)
Table 63. North America Minimal Residual Disease Testing Consumption Value by Type (2020-2025) & (USD Million)
Table 64. North America Minimal Residual Disease Testing Consumption Value by Type (2026-2031) & (USD Million)
Table 65. North America Minimal Residual Disease Testing Consumption Value by Application (2020-2025) & (USD Million)
Table 66. North America Minimal Residual Disease Testing Consumption Value by Application (2026-2031) & (USD Million)
Table 67. North America Minimal Residual Disease Testing Consumption Value by Country (2020-2025) & (USD Million)
Table 68. North America Minimal Residual Disease Testing Consumption Value by Country (2026-2031) & (USD Million)
Table 69. Europe Minimal Residual Disease Testing Consumption Value by Type (2020-2025) & (USD Million)
Table 70. Europe Minimal Residual Disease Testing Consumption Value by Type (2026-2031) & (USD Million)
Table 71. Europe Minimal Residual Disease Testing Consumption Value by Application (2020-2025) & (USD Million)
Table 72. Europe Minimal Residual Disease Testing Consumption Value by Application (2026-2031) & (USD Million)
Table 73. Europe Minimal Residual Disease Testing Consumption Value by Country (2020-2025) & (USD Million)
Table 74. Europe Minimal Residual Disease Testing Consumption Value by Country (2026-2031) & (USD Million)
Table 75. Asia-Pacific Minimal Residual Disease Testing Consumption Value by Type (2020-2025) & (USD Million)
Table 76. Asia-Pacific Minimal Residual Disease Testing Consumption Value by Type (2026-2031) & (USD Million)
Table 77. Asia-Pacific Minimal Residual Disease Testing Consumption Value by Application (2020-2025) & (USD Million)
Table 78. Asia-Pacific Minimal Residual Disease Testing Consumption Value by Application (2026-2031) & (USD Million)
Table 79. Asia-Pacific Minimal Residual Disease Testing Consumption Value by Region (2020-2025) & (USD Million)
Table 80. Asia-Pacific Minimal Residual Disease Testing Consumption Value by Region (2026-2031) & (USD Million)
Table 81. South America Minimal Residual Disease Testing Consumption Value by Type (2020-2025) & (USD Million)
Table 82. South America Minimal Residual Disease Testing Consumption Value by Type (2026-2031) & (USD Million)
Table 83. South America Minimal Residual Disease Testing Consumption Value by Application (2020-2025) & (USD Million)
Table 84. South America Minimal Residual Disease Testing Consumption Value by Application (2026-2031) & (USD Million)
Table 85. South America Minimal Residual Disease Testing Consumption Value by Country (2020-2025) & (USD Million)
Table 86. South America Minimal Residual Disease Testing Consumption Value by Country (2026-2031) & (USD Million)
Table 87. Middle East & Africa Minimal Residual Disease Testing Consumption Value by Type (2020-2025) & (USD Million)
Table 88. Middle East & Africa Minimal Residual Disease Testing Consumption Value by Type (2026-2031) & (USD Million)
Table 89. Middle East & Africa Minimal Residual Disease Testing Consumption Value by Application (2020-2025) & (USD Million)
Table 90. Middle East & Africa Minimal Residual Disease Testing Consumption Value by Application (2026-2031) & (USD Million)
Table 91. Middle East & Africa Minimal Residual Disease Testing Consumption Value by Country (2020-2025) & (USD Million)
Table 92. Middle East & Africa Minimal Residual Disease Testing Consumption Value by Country (2026-2031) & (USD Million)
Table 93. Global Key Players of Minimal Residual Disease Testing Upstream (Raw Materials)
Table 94. Global Minimal Residual Disease Testing Typical Customers
LIST OF FIGURES
Figure 1. Minimal Residual Disease Testing Picture
Figure 2. Global Minimal Residual Disease Testing Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Minimal Residual Disease Testing Consumption Value Market Share by Type in 2024
Figure 4. Flow Cytometry
Figure 5. Polymerase Chain Reaction
Figure 6. Global Minimal Residual Disease Testing Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Minimal Residual Disease Testing Consumption Value Market Share by Application in 2024
Figure 8. Hospitals and Specialty Clinics Picture
Figure 9. Diagnostic Laboratories Picture
Figure 10. Academic and Research Institutes Picture
Figure 11. Others Picture
Figure 12. Global Minimal Residual Disease Testing Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Minimal Residual Disease Testing Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Market Minimal Residual Disease Testing Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 15. Global Minimal Residual Disease Testing Consumption Value Market Share by Region (2020-2031)
Figure 16. Global Minimal Residual Disease Testing Consumption Value Market Share by Region in 2024
Figure 17. North America Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 18. Europe Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 19. Asia-Pacific Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 20. South America Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 21. Middle East & Africa Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 22. Company Three Recent Developments and Future Plans
Figure 23. Global Minimal Residual Disease Testing Revenue Share by Players in 2024
Figure 24. Minimal Residual Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 25. Market Share of Minimal Residual Disease Testing by Player Revenue in 2024
Figure 26. Top 3 Minimal Residual Disease Testing Players Market Share in 2024
Figure 27. Top 6 Minimal Residual Disease Testing Players Market Share in 2024
Figure 28. Global Minimal Residual Disease Testing Consumption Value Share by Type (2020-2025)
Figure 29. Global Minimal Residual Disease Testing Market Share Forecast by Type (2026-2031)
Figure 30. Global Minimal Residual Disease Testing Consumption Value Share by Application (2020-2025)
Figure 31. Global Minimal Residual Disease Testing Market Share Forecast by Application (2026-2031)
Figure 32. North America Minimal Residual Disease Testing Consumption Value Market Share by Type (2020-2031)
Figure 33. North America Minimal Residual Disease Testing Consumption Value Market Share by Application (2020-2031)
Figure 34. North America Minimal Residual Disease Testing Consumption Value Market Share by Country (2020-2031)
Figure 35. United States Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 36. Canada Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 37. Mexico Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 38. Europe Minimal Residual Disease Testing Consumption Value Market Share by Type (2020-2031)
Figure 39. Europe Minimal Residual Disease Testing Consumption Value Market Share by Application (2020-2031)
Figure 40. Europe Minimal Residual Disease Testing Consumption Value Market Share by Country (2020-2031)
Figure 41. Germany Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 42. France Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 43. United Kingdom Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 44. Russia Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 45. Italy Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 46. Asia-Pacific Minimal Residual Disease Testing Consumption Value Market Share by Type (2020-2031)
Figure 47. Asia-Pacific Minimal Residual Disease Testing Consumption Value Market Share by Application (2020-2031)
Figure 48. Asia-Pacific Minimal Residual Disease Testing Consumption Value Market Share by Region (2020-2031)
Figure 49. China Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 50. Japan Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 51. South Korea Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 52. India Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 53. Southeast Asia Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 54. Australia Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 55. South America Minimal Residual Disease Testing Consumption Value Market Share by Type (2020-2031)
Figure 56. South America Minimal Residual Disease Testing Consumption Value Market Share by Application (2020-2031)
Figure 57. South America Minimal Residual Disease Testing Consumption Value Market Share by Country (2020-2031)
Figure 58. Brazil Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 59. Argentina Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 60. Middle East & Africa Minimal Residual Disease Testing Consumption Value Market Share by Type (2020-2031)
Figure 61. Middle East & Africa Minimal Residual Disease Testing Consumption Value Market Share by Application (2020-2031)
Figure 62. Middle East & Africa Minimal Residual Disease Testing Consumption Value Market Share by Country (2020-2031)
Figure 63. Turkey Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 64. Saudi Arabia Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 65. UAE Minimal Residual Disease Testing Consumption Value (2020-2031) & (USD Million)
Figure 66. Minimal Residual Disease Testing Market Drivers
Figure 67. Minimal Residual Disease Testing Market Restraints
Figure 68. Minimal Residual Disease Testing Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Minimal Residual Disease Testing Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
